|
|
||||||||||||||||||||||||||||||||||||
|
Please E-mail suggested additions, comments and/or corrections to Kent@MoreLaw.Com. Date: 02-27-2004 Case Style: Ronald Gunderson v. Novartis Pharmaceuticals Corporation and Novartis Pharmaceuticals Corp. Case Number: Unknown Judge: Unknown Court: Circuit Court, Jefferson County, Kentucky Plaintiff's Attorney: Unknown Defendant's Attorney: Unknown Description: Wrongful death products liability claim by Ronald Gunerson individually and on behalf of the estate of Mary Gunderson against Novartis Pharmaceuticals Corp. and the estate of Dr. Lyman Armstrong. Armstrong gave Mary Gunderson Parlodel (bromocriptine mesylate), manufactured by sold by Novartis, to surpress Mrs. Gunderson's breast milk production after the birth of a child. The plaintiffs claimed that Novartis knew that Parlodel had serious side effects but failed to inform Armstrong. They said the drug was unreasonably dangerous and defective and caused Mary Gunderson to have a seizure and die. She was 32-years-old when she died in 1993 leaving her husband and two children. Outcome: Plaintiffs' verdict for $20 million including $18.3 against Novarits and $784,826 against the estate of Lyman Armstrong. Plaintiff's Experts: Unknown Defendant's Experts: Unknown Comments: None |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
